Composition containing beta-glucan for prevention and treatment of osteoporosis
US7671039B2 · kind B2 · utility
0Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 2004 |
| Grant date | Mar 2, 2010 |
| Priority date | — |
| Expiry date | Nov 20, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/716
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a composition containing beta-glucan as an effective ingredient for prevention and treatment of osteoporosis. The above captioned beta-glucan is preferably the beta-1.3/1.6 glucan having a lactic acid as a substituent and this beta-1.3/1.6 glucan is preferably produced from Aureobasidium pullulans SM2001(KCCM 10307).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.